Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 7.86020713 |
2 | negative thymic T cell selection (GO:0045060) | 7.78437275 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.89666221 |
4 | response to interleukin-15 (GO:0070672) | 6.86206849 |
5 | cellular response to interleukin-15 (GO:0071350) | 6.82003743 |
6 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.70793299 |
7 | positive thymic T cell selection (GO:0045059) | 6.58446956 |
8 | thymic T cell selection (GO:0045061) | 6.56065585 |
9 | negative regulation of cell killing (GO:0031342) | 6.37584858 |
10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.37584858 |
11 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.34160855 |
12 | T cell selection (GO:0045058) | 6.14590644 |
13 | positive T cell selection (GO:0043368) | 6.02633617 |
14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.01682750 |
15 | interferon-gamma production (GO:0032609) | 5.98224375 |
16 | regulation of gamma-delta T cell activation (GO:0046643) | 5.58716374 |
17 | leukocyte aggregation (GO:0070486) | 5.49917638 |
18 | regulation of T cell tolerance induction (GO:0002664) | 5.47999688 |
19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.37614915 |
20 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.37614915 |
21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.14799122 |
22 | T cell receptor signaling pathway (GO:0050852) | 5.13848508 |
23 | * tolerance induction (GO:0002507) | 5.13333699 |
24 | * lymphocyte costimulation (GO:0031294) | 5.11585772 |
25 | * T cell costimulation (GO:0031295) | 5.08237645 |
26 | T cell migration (GO:0072678) | 4.95487535 |
27 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.91679446 |
28 | positive regulation of T cell differentiation in thymus (GO:0033089) | 4.84672589 |
29 | T-helper cell differentiation (GO:0042093) | 4.56790902 |
30 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.56790902 |
31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.55717294 |
32 | positive regulation of tolerance induction (GO:0002645) | 4.44465327 |
33 | regulation of chronic inflammatory response (GO:0002676) | 4.40341814 |
34 | regulation of isotype switching (GO:0045191) | 4.36927404 |
35 | regulation of regulatory T cell differentiation (GO:0045589) | 4.36328733 |
36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.35688842 |
37 | positive regulation of isotype switching (GO:0045830) | 4.27533643 |
38 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.26853522 |
39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.21455183 |
40 | positive regulation of interleukin-2 production (GO:0032743) | 4.15002153 |
41 | T cell differentiation involved in immune response (GO:0002292) | 4.13450456 |
42 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.13450456 |
43 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.13450456 |
44 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.09592740 |
45 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.06769145 |
46 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.06769145 |
47 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.02932018 |
48 | regulation of tolerance induction (GO:0002643) | 4.01861965 |
49 | regulation of immunoglobulin production (GO:0002637) | 4.01762798 |
50 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.00497442 |
51 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.00497442 |
52 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.99116822 |
53 | alpha-beta T cell differentiation (GO:0046632) | 3.93029637 |
54 | positive regulation of immunoglobulin production (GO:0002639) | 3.88631700 |
55 | alpha-beta T cell activation (GO:0046631) | 3.85639433 |
56 | negative regulation of T cell apoptotic process (GO:0070233) | 3.84514257 |
57 | negative regulation of T cell mediated immunity (GO:0002710) | 3.82737670 |
58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.80333956 |
59 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.80310665 |
60 | Peyers patch development (GO:0048541) | 3.80310665 |
61 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.78454410 |
62 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.76029073 |
63 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.75101139 |
64 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.74480749 |
65 | positive regulation of B cell mediated immunity (GO:0002714) | 3.74480749 |
66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.74028914 |
67 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.69959227 |
68 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.68277521 |
69 | positive regulation of DNA recombination (GO:0045911) | 3.67744069 |
70 | regulation of response to interferon-gamma (GO:0060330) | 3.67591893 |
71 | T cell differentiation (GO:0030217) | 3.67242468 |
72 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.66667281 |
73 | regulation of B cell mediated immunity (GO:0002712) | 3.64453754 |
74 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.61954288 |
75 | regulation of memory T cell differentiation (GO:0043380) | 3.60051726 |
76 | RNA destabilization (GO:0050779) | 3.56544546 |
77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.56272310 |
78 | regulation of immunoglobulin secretion (GO:0051023) | 3.53954914 |
79 | regulation of cell killing (GO:0031341) | 3.52714107 |
80 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.50044188 |
81 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.48772253 |
82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.46422527 |
83 | NIK/NF-kappaB signaling (GO:0038061) | 3.45635040 |
84 | T cell activation involved in immune response (GO:0002286) | 3.45533368 |
85 | activated T cell proliferation (GO:0050798) | 3.44146466 |
86 | positive regulation of cell killing (GO:0031343) | 3.43291724 |
87 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.40263317 |
88 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.38618368 |
89 | B cell receptor signaling pathway (GO:0050853) | 3.36836933 |
90 | positive regulation of T cell mediated immunity (GO:0002711) | 3.36138438 |
91 | positive regulation of defense response to virus by host (GO:0002230) | 3.34925758 |
92 | regulation of interleukin-2 production (GO:0032663) | 3.34848818 |
93 | zinc ion homeostasis (GO:0055069) | 3.31938769 |
94 | mature B cell differentiation involved in immune response (GO:0002313) | 3.30565146 |
95 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.30562535 |
96 | T cell activation (GO:0042110) | 3.27720899 |
97 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.26378365 |
98 | natural killer cell activation (GO:0030101) | 3.25714818 |
99 | positive regulation of T cell differentiation (GO:0045582) | 3.25709442 |
100 | regulation of defense response to virus by virus (GO:0050690) | 3.24392729 |
101 | negative regulation of interleukin-12 production (GO:0032695) | 3.24294019 |
102 | lymph node development (GO:0048535) | 3.23068159 |
103 | regulation of alpha-beta T cell activation (GO:0046634) | 3.20427310 |
104 | positive regulation of granulocyte differentiation (GO:0030854) | 3.20300965 |
105 | myeloid dendritic cell differentiation (GO:0043011) | 3.18831692 |
106 | positive regulation of humoral immune response (GO:0002922) | 3.18789672 |
107 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.18526987 |
108 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.16804081 |
109 | mast cell activation (GO:0045576) | 3.15607942 |
110 | leukocyte cell-cell adhesion (GO:0007159) | 3.15203049 |
111 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.13553481 |
112 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.13436320 |
113 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.12821379 |
114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.12043283 |
115 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.11560981 |
116 | sequestering of actin monomers (GO:0042989) | 3.11412329 |
117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10790515 |
118 | regulation of T cell mediated immunity (GO:0002709) | 3.10293525 |
119 | positive regulation of lymphocyte differentiation (GO:0045621) | 3.10274226 |
120 | regulation of T cell differentiation in thymus (GO:0033081) | 3.09918052 |
121 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.09645094 |
122 | cellular zinc ion homeostasis (GO:0006882) | 3.08292411 |
123 | negative regulation of innate immune response (GO:0045824) | 3.07896859 |
124 | regulation of alpha-beta T cell differentiation (GO:0046637) | 3.05233277 |
125 | protein K11-linked deubiquitination (GO:0035871) | 3.02563789 |
126 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01862274 |
127 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.01271782 |
128 | mast cell activation involved in immune response (GO:0002279) | 2.99436013 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.73294307 |
2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.04705731 |
3 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.57623020 |
4 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.01685550 |
5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.99050241 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90167475 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.78828513 |
8 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.55179228 |
9 | * MYB_26560356_Chip-Seq_TH2_Human | 3.52935946 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.50587234 |
11 | MYC_22102868_ChIP-Seq_BL_Human | 3.22521739 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.22414485 |
13 | MAF_26560356_Chip-Seq_TH1_Human | 3.16203592 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.04645521 |
15 | MYB_26560356_Chip-Seq_TH1_Human | 2.94623042 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.88026415 |
17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.67926782 |
18 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.53622279 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49047265 |
20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.30726874 |
21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28949006 |
22 | MAF_26560356_Chip-Seq_TH2_Human | 2.27499713 |
23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.21682828 |
24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.13002251 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12440200 |
26 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.11365714 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.02462428 |
28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98180607 |
29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95952162 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.95399905 |
31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94219428 |
32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.92065062 |
33 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80508586 |
34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80305338 |
35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79538951 |
36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77004045 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71755604 |
38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.71024040 |
39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69602667 |
40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67531652 |
41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65573930 |
42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64668147 |
43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58155203 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58005059 |
45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47297303 |
46 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46622329 |
47 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.42660580 |
48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40569568 |
49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33958072 |
50 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31973215 |
51 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.31557925 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29112464 |
53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28550697 |
54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25616172 |
55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22370911 |
56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21790173 |
57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21421632 |
58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.21365670 |
59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20318419 |
60 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18238997 |
61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17059961 |
62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.13799514 |
63 | GATA3_26560356_Chip-Seq_TH1_Human | 1.12878768 |
64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07033155 |
65 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06991343 |
66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02390519 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01333694 |
68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01191261 |
69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00335314 |
70 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97700788 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96873569 |
72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96077209 |
73 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.95826983 |
74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95398915 |
75 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.94585545 |
76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93421585 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.91877447 |
78 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88918541 |
79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88830038 |
80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88429967 |
81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86072999 |
82 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.85536844 |
83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85224552 |
84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84066329 |
85 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82757882 |
86 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82558556 |
87 | P300_27268052_Chip-Seq_Bcells_Human | 0.82436337 |
88 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81517824 |
89 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.81424755 |
90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81127693 |
91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79592337 |
92 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.78829075 |
93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.78622577 |
94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78418383 |
95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78293456 |
96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77753765 |
97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76504968 |
98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.76236434 |
99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74877885 |
100 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.74821913 |
101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74291251 |
102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73824648 |
103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73411772 |
104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.73001961 |
105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72558610 |
106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.72498500 |
107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.71804594 |
108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70623216 |
109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.70126693 |
110 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69846891 |
111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69417744 |
112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.68361293 |
113 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.68182080 |
114 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.67371821 |
115 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67006537 |
116 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.66694726 |
117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.66635677 |
118 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.66324284 |
119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.64628050 |
120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64448600 |
121 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64441552 |
122 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.62923999 |
123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61700497 |
124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.61137199 |
125 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60262165 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 5.42912261 |
2 | MP0005671_abnormal_response_to | 5.21009045 |
3 | MP0000685_abnormal_immune_system | 3.37051369 |
4 | MP0001800_abnormal_humoral_immune | 3.26170013 |
5 | MP0001835_abnormal_antigen_presentation | 3.24204915 |
6 | MP0001790_abnormal_immune_system | 3.24002137 |
7 | MP0005387_immune_system_phenotype | 3.24002137 |
8 | MP0003300_gastrointestinal_ulcer | 3.08331653 |
9 | * MP0005000_abnormal_immune_tolerance | 3.07720353 |
10 | MP0009333_abnormal_splenocyte_physiolog | 3.01575321 |
11 | MP0002166_altered_tumor_susceptibility | 3.00250521 |
12 | MP0002723_abnormal_immune_serum | 2.86768790 |
13 | MP0001873_stomach_inflammation | 2.85554470 |
14 | MP0009785_altered_susceptibility_to | 2.81654955 |
15 | MP0003724_increased_susceptibility_to | 2.77646025 |
16 | MP0002420_abnormal_adaptive_immunity | 2.73645544 |
17 | * MP0001819_abnormal_immune_cell | 2.66774873 |
18 | MP0002398_abnormal_bone_marrow | 2.63681509 |
19 | MP0006082_CNS_inflammation | 2.54216236 |
20 | MP0002933_joint_inflammation | 2.52323294 |
21 | MP0002405_respiratory_system_inflammati | 2.51699341 |
22 | MP0010155_abnormal_intestine_physiology | 2.49786901 |
23 | * MP0002452_abnormal_antigen_presenting | 2.47433056 |
24 | MP0002006_tumorigenesis | 2.47171532 |
25 | MP0003436_decreased_susceptibility_to | 2.45541806 |
26 | MP0003303_peritoneal_inflammation | 2.43318381 |
27 | MP0004510_myositis | 2.41663272 |
28 | MP0000703_abnormal_thymus_morphology | 2.40691396 |
29 | * MP0005025_abnormal_response_to | 2.36385272 |
30 | MP0003866_abnormal_defecation | 2.34469107 |
31 | * MP0000716_abnormal_immune_system | 2.30733225 |
32 | MP0004947_skin_inflammation | 2.19845985 |
33 | MP0000569_abnormal_digit_pigmentation | 2.17707120 |
34 | * MP0002722_abnormal_immune_system | 2.07894157 |
35 | MP0000689_abnormal_spleen_morphology | 1.98735016 |
36 | MP0001853_heart_inflammation | 1.93903044 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.83850958 |
38 | * MP0002429_abnormal_blood_cell | 1.83752831 |
39 | MP0001845_abnormal_inflammatory_respons | 1.78011893 |
40 | MP0002396_abnormal_hematopoietic_system | 1.75389858 |
41 | MP0005310_abnormal_salivary_gland | 1.72206925 |
42 | MP0002419_abnormal_innate_immunity | 1.71577390 |
43 | MP0005408_hypopigmentation | 1.64448315 |
44 | MP0001919_abnormal_reproductive_system | 1.60845338 |
45 | MP0000858_altered_metastatic_potential | 1.48130147 |
46 | MP0003448_altered_tumor_morphology | 1.36737843 |
47 | MP0000490_abnormal_crypts_of | 1.33904300 |
48 | MP0002009_preneoplasia | 1.29664476 |
49 | MP0000465_gastrointestinal_hemorrhage | 1.28061191 |
50 | MP0005464_abnormal_platelet_physiology | 1.26570250 |
51 | MP0001533_abnormal_skeleton_physiology | 1.26415717 |
52 | MP0000371_diluted_coat_color | 1.25940415 |
53 | MP0001851_eye_inflammation | 1.16551433 |
54 | MP0004808_abnormal_hematopoietic_stem | 1.16244668 |
55 | * MP0008469_abnormal_protein_level | 1.15183475 |
56 | MP0003045_fibrosis | 1.10471274 |
57 | MP0001348_abnormal_lacrimal_gland | 1.09676217 |
58 | MP0005174_abnormal_tail_pigmentation | 1.05285837 |
59 | MP0003172_abnormal_lysosome_physiology | 1.04126933 |
60 | MP0010352_gastrointestinal_tract_polyps | 1.03171309 |
61 | MP0000015_abnormal_ear_pigmentation | 1.03085795 |
62 | MP0002998_abnormal_bone_remodeling | 0.98689638 |
63 | MP0004381_abnormal_hair_follicle | 0.97583568 |
64 | MP0002138_abnormal_hepatobiliary_system | 0.94721634 |
65 | MP0001545_abnormal_hematopoietic_system | 0.94167580 |
66 | MP0005397_hematopoietic_system_phenotyp | 0.94167580 |
67 | MP0005076_abnormal_cell_differentiation | 0.92169892 |
68 | MP0002019_abnormal_tumor_incidence | 0.90981163 |
69 | MP0002254_reproductive_system_inflammat | 0.90168951 |
70 | MP0002163_abnormal_gland_morphology | 0.89905938 |
71 | MP0005023_abnormal_wound_healing | 0.86630912 |
72 | MP0008961_abnormal_basal_metabolism | 0.86044490 |
73 | MP0003828_pulmonary_edema | 0.85729940 |
74 | MP0003252_abnormal_bile_duct | 0.81225746 |
75 | MP0009763_increased_sensitivity_to | 0.77880504 |
76 | MP0001501_abnormal_sleep_pattern | 0.73136733 |
77 | MP0004130_abnormal_muscle_cell | 0.73051831 |
78 | MP0001243_abnormal_dermal_layer | 0.72153277 |
79 | MP0005389_reproductive_system_phenotype | 0.71006226 |
80 | MP0001881_abnormal_mammary_gland | 0.70162892 |
81 | MP0002876_abnormal_thyroid_physiology | 0.68986326 |
82 | MP0000604_amyloidosis | 0.68693857 |
83 | MP0001663_abnormal_digestive_system | 0.68571732 |
84 | MP0009765_abnormal_xenobiotic_induced | 0.67643662 |
85 | MP0008007_abnormal_cellular_replicative | 0.66912858 |
86 | MP0000249_abnormal_blood_vessel | 0.65405154 |
87 | MP0009764_decreased_sensitivity_to | 0.65296712 |
88 | MP0008057_abnormal_DNA_replication | 0.65006340 |
89 | MP0003795_abnormal_bone_structure | 0.64726655 |
90 | * MP0000477_abnormal_intestine_morphology | 0.63560671 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.61967886 |
92 | MP0000343_altered_response_to | 0.61752624 |
93 | MP0000609_abnormal_liver_physiology | 0.61501197 |
94 | MP0001986_abnormal_taste_sensitivity | 0.60255196 |
95 | MP0003787_abnormal_imprinting | 0.58405212 |
96 | MP0002102_abnormal_ear_morphology | 0.57696428 |
97 | MP0001216_abnormal_epidermal_layer | 0.57304359 |
98 | MP0005075_abnormal_melanosome_morpholog | 0.57168193 |
99 | MP0002132_abnormal_respiratory_system | 0.55899650 |
100 | MP0002075_abnormal_coat/hair_pigmentati | 0.55237509 |
101 | MP0008873_increased_physiological_sensi | 0.53083933 |
102 | MP0009840_abnormal_foam_cell | 0.53057571 |
103 | MP0002822_catalepsy | 0.51221611 |
104 | MP0005166_decreased_susceptibility_to | 0.51080403 |
105 | MP0005165_increased_susceptibility_to | 0.49853354 |
106 | MP0002653_abnormal_ependyma_morphology | 0.49262966 |
107 | MP0000367_abnormal_coat/_hair | 0.47711259 |
108 | MP0001765_abnormal_ion_homeostasis | 0.46916133 |
109 | MP0001849_ear_inflammation | 0.46825021 |
110 | MP0003091_abnormal_cell_migration | 0.46453874 |
111 | MP0002277_abnormal_respiratory_mucosa | 0.45948508 |
112 | MP0001502_abnormal_circadian_rhythm | 0.45422121 |
113 | MP0002136_abnormal_kidney_physiology | 0.45217220 |
114 | MP0003077_abnormal_cell_cycle | 0.45203416 |
115 | MP0001191_abnormal_skin_condition | 0.45101221 |
116 | MP0005390_skeleton_phenotype | 0.44921128 |
117 | MP0001119_abnormal_female_reproductive | 0.43703747 |
118 | MP0005379_endocrine/exocrine_gland_phen | 0.42790789 |
119 | MP0010234_abnormal_vibrissa_follicle | 0.41984266 |
120 | MP0000627_abnormal_mammary_gland | 0.41492994 |
121 | MP0008872_abnormal_physiological_respon | 0.40120543 |
122 | MP0009697_abnormal_copulation | 0.38791696 |
123 | MP0009278_abnormal_bone_marrow | 0.37566807 |
124 | MP0000598_abnormal_liver_morphology | 0.37315564 |
125 | MP0002877_abnormal_melanocyte_morpholog | 0.35813647 |
126 | * MP0002693_abnormal_pancreas_physiology | 0.35698511 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Retrobulbar optic neuritis (HP:0100654) | 7.13493368 |
2 | Optic neuritis (HP:0100653) | 7.13493368 |
3 | Myositis (HP:0100614) | 7.02187307 |
4 | T lymphocytopenia (HP:0005403) | 6.74429483 |
5 | Abnormality of T cell number (HP:0011839) | 6.56647593 |
6 | Orchitis (HP:0100796) | 6.32065079 |
7 | Severe combined immunodeficiency (HP:0004430) | 5.77824732 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.73431750 |
9 | Stomatitis (HP:0010280) | 5.42193880 |
10 | Combined immunodeficiency (HP:0005387) | 5.12437576 |
11 | Keratoconjunctivitis sicca (HP:0001097) | 4.83793032 |
12 | * Abnormality of T cells (HP:0002843) | 4.63707852 |
13 | Recurrent fungal infections (HP:0002841) | 4.46375973 |
14 | Pulmonary infiltrates (HP:0002113) | 4.44209116 |
15 | Hemoptysis (HP:0002105) | 4.39096701 |
16 | Keratoconjunctivitis (HP:0001096) | 4.38606889 |
17 | Eczematoid dermatitis (HP:0000976) | 4.22338205 |
18 | Increased IgM level (HP:0003496) | 4.11233334 |
19 | Chronic diarrhea (HP:0002028) | 4.08294956 |
20 | Arterial thrombosis (HP:0004420) | 4.08123812 |
21 | Panhypogammaglobulinemia (HP:0003139) | 3.90524813 |
22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.84805899 |
23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.84805899 |
24 | Autoimmune hemolytic anemia (HP:0001890) | 3.83601206 |
25 | Gangrene (HP:0100758) | 3.76724437 |
26 | Nasal polyposis (HP:0100582) | 3.74945825 |
27 | * IgG deficiency (HP:0004315) | 3.73244203 |
28 | Abnormality of eosinophils (HP:0001879) | 3.70663182 |
29 | Joint swelling (HP:0001386) | 3.65082691 |
30 | Pulmonary embolism (HP:0002204) | 3.63408463 |
31 | Gastrointestinal infarctions (HP:0005244) | 3.62649654 |
32 | * Recurrent bronchitis (HP:0002837) | 3.55703632 |
33 | * Vasculitis (HP:0002633) | 3.50851834 |
34 | Chronic otitis media (HP:0000389) | 3.50332487 |
35 | Pustule (HP:0200039) | 3.47876774 |
36 | Encephalitis (HP:0002383) | 3.46269482 |
37 | Recurrent viral infections (HP:0004429) | 3.43994773 |
38 | Abnormality of the fingertips (HP:0001211) | 3.43810767 |
39 | Stomach cancer (HP:0012126) | 3.42963722 |
40 | Thyroiditis (HP:0100646) | 3.40135264 |
41 | Meningitis (HP:0001287) | 3.31638110 |
42 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.30637526 |
43 | Leukocytosis (HP:0001974) | 3.21242678 |
44 | Abnormality of the nasal mucosa (HP:0000433) | 3.13335119 |
45 | Anorexia (HP:0002039) | 3.11195618 |
46 | Eosinophilia (HP:0001880) | 2.98515549 |
47 | Abnormality of the prostate (HP:0008775) | 2.97532563 |
48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91681907 |
49 | Obstructive lung disease (HP:0006536) | 2.91681907 |
50 | * IgM deficiency (HP:0002850) | 2.85161285 |
51 | Hypergammaglobulinemia (HP:0010702) | 2.84952790 |
52 | Ureteral stenosis (HP:0000071) | 2.82994799 |
53 | Increased density of long bones (HP:0006392) | 2.82297412 |
54 | Chest pain (HP:0100749) | 2.78423848 |
55 | * Abnormality of B cell number (HP:0010975) | 2.77247479 |
56 | * Abnormality of T cell physiology (HP:0011840) | 2.72808298 |
57 | Prostate neoplasm (HP:0100787) | 2.66789101 |
58 | Glomerulopathy (HP:0100820) | 2.66433577 |
59 | Polyneuropathy (HP:0001271) | 2.62657005 |
60 | Granulocytopenia (HP:0001913) | 2.61417205 |
61 | * Lymphopenia (HP:0001888) | 2.60416599 |
62 | Adactyly (HP:0009776) | 2.59515520 |
63 | Ureteral obstruction (HP:0006000) | 2.57331975 |
64 | Abnormality of the pleura (HP:0002103) | 2.57219367 |
65 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.54167339 |
66 | Increased IgE level (HP:0003212) | 2.51471427 |
67 | * B lymphocytopenia (HP:0010976) | 2.48858551 |
68 | Thrombophlebitis (HP:0004418) | 2.48179456 |
69 | * IgA deficiency (HP:0002720) | 2.47756201 |
70 | Mediastinal lymphadenopathy (HP:0100721) | 2.47636477 |
71 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.42218557 |
72 | Fibular aplasia (HP:0002990) | 2.41974819 |
73 | Abnormality of the pericardium (HP:0001697) | 2.41530574 |
74 | Keratitis (HP:0000491) | 2.40040796 |
75 | Spontaneous hematomas (HP:0007420) | 2.39763733 |
76 | Thrombocytosis (HP:0001894) | 2.36968804 |
77 | Abnormality of the endocardium (HP:0004306) | 2.36930010 |
78 | Oligodactyly (hands) (HP:0001180) | 2.34297624 |
79 | Inflammation of the large intestine (HP:0002037) | 2.29566045 |
80 | * Lymphoma (HP:0002665) | 2.28088018 |
81 | Basal cell carcinoma (HP:0002671) | 2.27215039 |
82 | Persistence of primary teeth (HP:0006335) | 2.27120577 |
83 | Hypoplasia of the thymus (HP:0000778) | 2.26457829 |
84 | Gastrointestinal inflammation (HP:0004386) | 2.25338151 |
85 | Recurrent skin infections (HP:0001581) | 2.21731945 |
86 | Enlarged epiphyses (HP:0010580) | 2.20258903 |
87 | Epistaxis (HP:0000421) | 2.16962876 |
88 | Radial bowing (HP:0002986) | 2.13989627 |
89 | Gingival bleeding (HP:0000225) | 2.11820180 |
90 | Albinism (HP:0001022) | 2.10722415 |
91 | Autoimmune thrombocytopenia (HP:0001973) | 2.10667352 |
92 | Cheilitis (HP:0100825) | 2.09056401 |
93 | Abnormality of the peritoneum (HP:0002585) | 2.04184950 |
94 | * Arthralgia (HP:0002829) | 2.03847944 |
95 | Amaurosis fugax (HP:0100576) | 1.98495498 |
96 | Thin bony cortex (HP:0002753) | 1.97646164 |
97 | Pulmonary fibrosis (HP:0002206) | 1.97568013 |
98 | Congenital stationary night blindness (HP:0007642) | 1.95472439 |
99 | Renal cortical cysts (HP:0000803) | 1.92080693 |
100 | Papilloma (HP:0012740) | 1.90856083 |
101 | Verrucae (HP:0200043) | 1.90856083 |
102 | Recurrent abscess formation (HP:0002722) | 1.90325451 |
103 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.89609907 |
104 | Interstitial pulmonary disease (HP:0006530) | 1.88997446 |
105 | Abnormality of male internal genitalia (HP:0000022) | 1.88145717 |
106 | Abnormality of the pons (HP:0007361) | 1.87946158 |
107 | Generalized hypopigmentation of hair (HP:0011358) | 1.86937644 |
108 | Abnormal platelet volume (HP:0011876) | 1.86921123 |
109 | Posterior subcapsular cataract (HP:0007787) | 1.85386994 |
110 | Ocular albinism (HP:0001107) | 1.84063062 |
111 | Recurrent bacterial skin infections (HP:0005406) | 1.83684272 |
112 | Synostosis involving the elbow (HP:0003938) | 1.83649523 |
113 | Humeroradial synostosis (HP:0003041) | 1.83649523 |
114 | * Bronchitis (HP:0012387) | 1.82690131 |
115 | Abnormality of alanine metabolism (HP:0010916) | 1.82569100 |
116 | Hyperalaninemia (HP:0003348) | 1.82569100 |
117 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82569100 |
118 | Cerebral ischemia (HP:0002637) | 1.82378374 |
119 | Agammaglobulinemia (HP:0004432) | 1.81876068 |
120 | Neoplasm of the lung (HP:0100526) | 1.81493279 |
121 | Abnormality of binocular vision (HP:0011514) | 1.80616008 |
122 | Diplopia (HP:0000651) | 1.80616008 |
123 | Vertigo (HP:0002321) | 1.79599996 |
124 | Skin ulcer (HP:0200042) | 1.78757216 |
125 | Alveolar cell carcinoma (HP:0006519) | 1.78529725 |
126 | Petechiae (HP:0000967) | 1.78123085 |
127 | Abnormality of the costochondral junction (HP:0000919) | 1.77470412 |
128 | Hypoplasia of the pons (HP:0012110) | 1.76455531 |
129 | Abnormal spermatogenesis (HP:0008669) | 1.74519604 |
130 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.74361221 |
131 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72729332 |
132 | Paresthesia (HP:0003401) | 1.69867778 |
133 | Chronic sinusitis (HP:0011109) | 1.68547214 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 8.06100091 |
2 | MAP4K1 | 5.30680854 |
3 | ITK | 3.38427443 |
4 | FGFR4 | 3.38356773 |
5 | ZAP70 | 3.38165661 |
6 | JAK3 | 3.33691593 |
7 | JAK1 | 2.53681445 |
8 | IKBKE | 2.42956123 |
9 | MAP3K9 | 2.38838677 |
10 | TYK2 | 2.36451546 |
11 | MAP3K14 | 2.23043953 |
12 | FGFR3 | 2.20671690 |
13 | STK10 | 2.07399633 |
14 | ARAF | 1.96418848 |
15 | TBK1 | 1.95207519 |
16 | TEC | 1.84367545 |
17 | LCK | 1.82673444 |
18 | BLK | 1.81967969 |
19 | KDR | 1.67906226 |
20 | NLK | 1.66716445 |
21 | GRK6 | 1.64721166 |
22 | EPHA3 | 1.62604964 |
23 | TESK2 | 1.52169385 |
24 | PASK | 1.49618867 |
25 | SYK | 1.48336757 |
26 | TAOK3 | 1.47437945 |
27 | MAP2K2 | 1.44209433 |
28 | HCK | 1.41133518 |
29 | RIPK4 | 1.40245411 |
30 | MAP4K2 | 1.35733851 |
31 | EPHB1 | 1.30437167 |
32 | CSK | 1.29300641 |
33 | BTK | 1.27948204 |
34 | CAMKK2 | 1.24026645 |
35 | PRKCQ | 1.21911296 |
36 | BMPR2 | 1.10517526 |
37 | IKBKB | 1.10443925 |
38 | KSR2 | 1.08925006 |
39 | IRAK3 | 1.06303406 |
40 | IRAK4 | 1.03269469 |
41 | JAK2 | 1.01553161 |
42 | CAMKK1 | 0.96146860 |
43 | EEF2K | 0.95744670 |
44 | CHUK | 0.93744675 |
45 | IRAK1 | 0.93673259 |
46 | TSSK6 | 0.93413317 |
47 | MAP3K12 | 0.89787191 |
48 | PRPF4B | 0.88816825 |
49 | ADRBK2 | 0.86925427 |
50 | PRKCH | 0.86554307 |
51 | PIM1 | 0.81867175 |
52 | MST4 | 0.81177341 |
53 | RAF1 | 0.80995904 |
54 | TLK1 | 0.80242835 |
55 | LRRK2 | 0.79898796 |
56 | TYRO3 | 0.79890162 |
57 | SIK3 | 0.79273885 |
58 | SIK2 | 0.79270761 |
59 | FES | 0.76629903 |
60 | KIT | 0.75753170 |
61 | CDK12 | 0.74896565 |
62 | MARK3 | 0.74797277 |
63 | MAP3K13 | 0.72633663 |
64 | MOS | 0.71277463 |
65 | TNK2 | 0.68075940 |
66 | NME2 | 0.67444989 |
67 | PRKCI | 0.65309343 |
68 | ZAK | 0.64479142 |
69 | PDGFRB | 0.64181878 |
70 | TGFBR2 | 0.64125214 |
71 | LYN | 0.63921903 |
72 | CSNK1G1 | 0.62261379 |
73 | RPS6KA4 | 0.60889459 |
74 | ALK | 0.60164623 |
75 | MAP3K7 | 0.60109757 |
76 | STK24 | 0.57985719 |
77 | CLK1 | 0.57348058 |
78 | FGFR1 | 0.56943708 |
79 | SGK2 | 0.56385244 |
80 | NEK6 | 0.56215214 |
81 | CDK6 | 0.55485464 |
82 | MAP3K10 | 0.54863138 |
83 | MAP3K1 | 0.54459250 |
84 | CDK4 | 0.54427377 |
85 | HIPK2 | 0.53532139 |
86 | TRIB3 | 0.53477059 |
87 | PIK3CA | 0.49563822 |
88 | PDK1 | 0.49238660 |
89 | WNK4 | 0.48373095 |
90 | MAPK7 | 0.46666728 |
91 | MAP2K6 | 0.46574433 |
92 | DMPK | 0.44563245 |
93 | MELK | 0.42443832 |
94 | TESK1 | 0.39910209 |
95 | BRD4 | 0.39601342 |
96 | MAPK12 | 0.39479014 |
97 | FYN | 0.39084117 |
98 | IGF1R | 0.38038410 |
99 | SGK494 | 0.37956585 |
100 | SGK223 | 0.37956585 |
101 | INSR | 0.37155129 |
102 | NUAK1 | 0.35679195 |
103 | KSR1 | 0.35370781 |
104 | RPS6KA5 | 0.33332565 |
105 | MAP2K1 | 0.32485441 |
106 | SGK3 | 0.31178766 |
107 | TAOK1 | 0.30230510 |
108 | CDK9 | 0.29500933 |
109 | CSF1R | 0.29301567 |
110 | MAPK11 | 0.27894888 |
111 | GRK1 | 0.27799352 |
112 | ILK | 0.27369128 |
113 | CSNK1A1L | 0.26935852 |
114 | SIK1 | 0.26540553 |
115 | FGFR2 | 0.26167043 |
116 | IRAK2 | 0.22980709 |
117 | NTRK2 | 0.22555821 |
118 | EIF2AK1 | 0.21843175 |
119 | MAPK3 | 0.20914347 |
120 | MAPKAPK2 | 0.20753931 |
121 | PKN2 | 0.19236972 |
122 | BRAF | 0.19178730 |
123 | GRK7 | 0.19053453 |
124 | NEK9 | 0.18619002 |
125 | NEK2 | 0.18464063 |
126 | SCYL2 | 0.18087354 |
127 | MARK2 | 0.17163585 |
128 | CDK8 | 0.17038469 |
129 | MAP3K11 | 0.16958249 |
130 | RET | 0.16223976 |
131 | PRKCD | 0.16061860 |
132 | PRKD2 | 0.14916114 |
133 | MAPK9 | 0.13567619 |
134 | TTN | 0.13081214 |
135 | MAP2K3 | 0.13025870 |
136 | EGFR | 0.12828428 |
137 | ABL1 | 0.12568558 |
138 | PTK6 | 0.11557020 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.85613775 |
2 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 4.83510101 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 4.38266132 |
4 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.00593019 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.77938447 |
6 | Asthma_Homo sapiens_hsa05310 | 3.24364472 |
7 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.15848485 |
8 | Measles_Homo sapiens_hsa05162 | 2.98335342 |
9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.60501341 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53801617 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28674155 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25961289 |
13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.25528072 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.08433170 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95531122 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.93461930 |
17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83596905 |
18 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.76322108 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.47135261 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42008044 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36973346 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.35894062 |
23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34241753 |
24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31144283 |
25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.23342552 |
26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21022017 |
27 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.20118238 |
28 | Hepatitis B_Homo sapiens_hsa05161 | 1.19063647 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17952080 |
30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.17588005 |
31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11688891 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.08700914 |
33 | Influenza A_Homo sapiens_hsa05164 | 1.05744111 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05420045 |
35 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04224582 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97759274 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96724726 |
38 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96705440 |
39 | Apoptosis_Homo sapiens_hsa04210 | 0.95503964 |
40 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94091650 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90489014 |
42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88273705 |
43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88009605 |
44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.87021273 |
45 | Malaria_Homo sapiens_hsa05144 | 0.83979119 |
46 | Legionellosis_Homo sapiens_hsa05134 | 0.80891376 |
47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75445055 |
48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75261899 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75010885 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 0.73900999 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.71848483 |
52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71697209 |
53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70828330 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66832733 |
55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65923464 |
56 | Tuberculosis_Homo sapiens_hsa05152 | 0.65545878 |
57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65248412 |
58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63646350 |
59 | Platelet activation_Homo sapiens_hsa04611 | 0.63568828 |
60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62214205 |
61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58155199 |
62 | Salmonella infection_Homo sapiens_hsa05132 | 0.57893993 |
63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.57743225 |
64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54009993 |
65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52910778 |
66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52642274 |
67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52619050 |
68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50287008 |
69 | Pertussis_Homo sapiens_hsa05133 | 0.49752185 |
70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49388560 |
71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47370153 |
72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44334069 |
73 | Endocytosis_Homo sapiens_hsa04144 | 0.44043418 |
74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42962470 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42766274 |
76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41642864 |
77 | Spliceosome_Homo sapiens_hsa03040 | 0.40916430 |
78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40546929 |
79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40147409 |
80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39667289 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39343438 |
82 | Ribosome_Homo sapiens_hsa03010 | 0.38802833 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.38123142 |
84 | RNA polymerase_Homo sapiens_hsa03020 | 0.38105639 |
85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37858110 |
86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37784574 |
87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34032596 |
88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33828113 |
89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32500998 |
90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32081973 |
91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31657035 |
92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31254494 |
93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31011292 |
94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29276008 |
95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.28519438 |
96 | RNA degradation_Homo sapiens_hsa03018 | 0.28021109 |
97 | Phototransduction_Homo sapiens_hsa04744 | 0.26350794 |
98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26217550 |
99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25373310 |
100 | Insulin resistance_Homo sapiens_hsa04931 | 0.25296045 |
101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.23881261 |
102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23230213 |
103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.23217487 |
104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23140304 |
105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.19647828 |
106 | Prostate cancer_Homo sapiens_hsa05215 | 0.18558596 |
107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17983678 |
108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17344262 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.14515251 |
110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.13456693 |
111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12584506 |
112 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.10209731 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.10146944 |
114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.09503379 |
115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09080009 |
116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.08148140 |
117 | Adherens junction_Homo sapiens_hsa04520 | 0.07805980 |
118 | Proteasome_Homo sapiens_hsa03050 | 0.07617520 |
119 | Base excision repair_Homo sapiens_hsa03410 | 0.06228273 |
120 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.05858352 |
121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05438769 |
122 | Focal adhesion_Homo sapiens_hsa04510 | 0.04308845 |